ProPhase Labs, Inc. (PRPH)

5.44 -0.83 (-13.24%) At close: 04:00PM EDT

ProPhase Labs, Inc.

711 Stewart Avenue
Suite 200
Garden City, NY 11530
United States
215 345 0919
https://www.prophaselabs.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 113

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ted William Karkus	Chairman & CEO	902.2k	N/A	1959
Mr. Jed A. Latkin	Chief Operating Officer & Head of Finance Department	N/A	N/A	1974
Mr. Robert A. Morse Jr.	Controller, Principal Financial Officer & Principal Accounting Officer	N/A	N/A	1975
Mr. Sergio Miralles	Executive VP & Chief Information Officer	N/A	N/A	N/A
Mr. Jason Karkus	President of Nebula Genomics	N/A	N/A	N/A
Mr. Kamal Obbad	Senior VP and Director of Sales & Marketing - Nebula Genomics	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It also offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Corporate governance

ProPhase Labs, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.